RSY Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index

Recom Managed Systems (AMEX: RSY) announced today that it has chosen Ventura, Calif.-based Ventrex, Inc. as its contract-manufacturing partner. Ventrex exclusively manufactures medical devices and has Fortune 100 companies among its clients. Ventrex has produced a wide range of medical products and has experience in producing monitoring devices that are similar to Recom's Model 100 in function and design. "The agreement with Ventrex to serve as our contract manufacturer is an important milestone for Recom," said Rod Hildebrandt, chief operating officer of Recom. "We were very diligent in our search for a manufacturer because it was important to us to find a quality organization like Ventrex with which we could partner for the long term. We are excited to begin the commercial production of the Recom Model 100." "We are pleased and honored to be selected as Recom's partner in the manufacture of their very promising new product," said Bob Guthrie, general manager of Ventrex. "The technology employed in this unique device fits well with our core capabilities. We are confident that this will be a long and mutually beneficial relationship." Ventrex is privately owned by its on-site management team, who have more than 20 years of experience in all facets of medical-device manufacturing. Ventrex's manufacturing facility is FDA-approved and ISO 13485-certified. The company has experienced seven years of steady growth while establishing a very impressive track record of producing high-quality products at competitive costs, and their on-time delivery rate is more than 98 percent. Recom and Ventrex have jointly initiated component part acquisition in order to commence production of the Model 100 as soon as practicable and definitely toward the end of the current calendar quarter. About Recom Managed Systems, Inc. Recom Managed Systems, Inc. is an emerging life-sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Recom Managed Systems, Inc. uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. With its patented signal-technology platform, Recom brings clinical-quality physiological signal monitoring to the ambulatory setting. Recom's first product, the Model 100 Heart Monitor, is an ambulatory patient heart monitor that uses patented signal-processing technology to record a clinical-quality ECG signal in the presence of interference generated by the patient's body movements and ambient environment. The Model 100 has received 510(k) clearance from the Food and Drug Administration. Recom Managed Systems, Inc. is traded on the American Stock Exchange under the symbol RSY. More information is located at http://www.recom-systems.com Caution Regarding Forward-Looking Statements Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknown risks, which may cause Recom's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of new products or services, failure to obtain federal or state regulatory approvals governing medical devices, monitoring and other related services or products, inability to obtain physician, patient or insurance acceptance of Recom's products or services, adverse equity-market conditions and declines in the value of Recom's common stock, and the unavailability of financing to complete management's plans and objectives. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Recom's filings with the Securities and Exchange Commission.